Phase Ib Trial of Obinutuzumab in Combination with Induction Chemotherapy Followed by Obinutuzumab Maintenance in FL


Phase Ib Trial of Obinutuzumab in Combination with Induction Chemotherapy Followed by Obinutuzumab Maintenance in FL
Slides from a presentation at ASH 2014 and transcribed comments from a recent interview with Jonathan W Friedberg, MD, MMSc (1/8/15)
Dyer MJS et al. Obinutuzumab (GA101) in combination with CHOP (cyclophosphamide, doxorubicin, vincristine and prednisone) or bendamustine for the first-line treatment of follicular non-Hodgkin lymphoma: Final results from the maintenance phase of the phase Ib GAUDI study. Proc ASH 2014;Abstract 1743.

Dr Friedberg is Samuel Durand Professor of Medicine and Director of the Wilmot Cancer Center at the University of Rochester in Rochester, New York.